(Press-News.org) WHAT:
In a review article appearing in the New England Journal of Medicine, scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine research under way to address the limitations of currently available influenza vaccines and develop more efficient and reliable strategies to make vaccines to protect against seasonal as well as pandemic influenza. Although licensed seasonal flu vaccines safely and effectively protect most people who receive them from illness and death, the degree of protection varies depending on how well the circulating virus strains and those in the vaccine match. A vaccine recipient's age and health status also can affect the effectiveness of influenza vaccination.
The authors discuss the spectrum of ongoing influenza vaccine research that may transform the field in decades to come. Efforts to grow the vaccine virus in cells rather than eggs are currently under way and there is consideration of the addition to influenza vaccine of immune-stimulating adjuvants to be used in certain groups of individuals. Other approaches under development include influenza vaccines based on recombinant virus proteins, non-infectious virus-like particles, harmless vectors or influenza DNA. Also under intense study is the ultimate goal, a so-called universal flu vaccine that would provide protection against multiple strains of influenza, reducing the need for yearly flu shots while simultaneously protecting against novel flu viruses that may arise in the future.
To further protect vulnerable populations such as the elderly and those with underlying chronic diseases from seasonal influenza, as well as to quickly control the spread of potential pandemic influenza viruses, influenza vaccine makers of the future must employ novel production technologies, the authors note.
INFORMATION:
More information about vaccine technologies and influenza vaccines is available on the NIAID Flu Web portal (http://www.niaid.nih.gov/topics/flu/Pages/default.aspx) and at the Advances in Influenza Vaccine Technologies videocast (http://videocast.nih.gov/summary.asp?file=15499).
ARTICLE:
AS Fauci and L Lambert. Influenza vaccines for the future. New England Journal of Medicine DOI: 10.1056/ NEJMra1002842 (2010).
WHO:
NIAID Director Anthony S. Fauci, M.D. is available to comment on the article.
CONTACT:
To schedule interviews, please contact Nalini Padmanabhan, 301-402-1663, niaidnews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH experts describe influenza vaccines of the future
2010-11-18
ELSE PRESS RELEASES FROM THIS DATE:
Structure of Lassa virus protein reveals viral thievery
2010-11-18
Scientists at Emory University and the University of St. Andrews have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever.
The structure reveals how the virus evades its host's immune system, and how it hijacks infected cells' vital machinery in a process scientists call "cap-stealing." Details of the structure could guide future efforts at antiviral drug discovery and vaccine development.
The results are published in this week's issue of Nature.
Lassa virus represents a family of viruses ...
Nation's top hospital organ transplant centers identified by HealthGrades
2010-11-18
GOLDEN, Colo. (November 17, 2010) – HealthGrades, the nation's leading independent ratings organization, today made available to organ transplant patients a list of those hospitals with the best track record for survival and chances of receiving a donor organ. HealthGrades annual evaluation of the nation's top-performing hospitals in organ transplantation includes clinical quality data, based on patient outcomes, for each of the 210 adult acute care hospitals that perform transplants. This information is available, free to the public, at HealthGrades.com and is intended ...
Multidisciplinary approach is key to successful treatment of aggressive prostate cancer
2010-11-18
PHILADELPHIA – A research team from the National Cancer Institute (NCI) designated Kimmel Cancer Center (KCC) at Jefferson has concluded – for the first time – that a multidisciplinary clinic approach to aggressive prostate cancer can improve survival in patients. The results from the 15-year study of the multidisciplinary clinic can be found in the November issue of Journal of Oncology Practice.
Stats and Treatment
Prostate cancer remains the most common non-skin cancer and the second leading cause of cancer death in men in the United States. In fact, about 218,000 ...
Lower back and foot pain associated with more severe knee osteoarthritis symptoms
2010-11-18
A new study found that patients with osteoarthritis (OA) of the knee who also have pain in other joints were more likely to experience greater knee pain. Specifically, pain in the lower back as well as foot pain and elbow pain on the same side as the affected knee were associated with more severe knee pain. Full details appear in the December issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Knee OA is the leading cause of disability in the U.S., with nearly 4.3 million adults over age 60 having ...
1-touch make-up -- for our cells
2010-11-18
VIDEO:
Cells from a pig's cardiovascular system with different components are labeled simultaneously, using the new Multi-Label technology.
Click here for more information.
The cells in the different parts of this video are always the same, but, like actors using make-up to highlight different facial features, they have fluorescent labels that mark different cellular components in different colours: blue shows the nucleus, yellow shows tubulin (a component of the cell's scaffolding), ...
Nurse practitioner-led spinal clinic produced impressive results and shorter waiting times
2010-11-18
Ninety-six per cent of patients with back problems were satisfied with the assessment carried out by a specially trained nurse practitioner, according to a study in the December issue of the Journal of Advanced Nursing.
Seventy-four per cent were happy to see her rather than wait up to a year to see a surgeon, with less than a quarter of those who preferred to see a surgeon saying that the extra wait was acceptable.
The pilot study at Toronto Western Hospital in Ontario, Canada, was judged a resounding success after nurse practitioner Angela Sarro came up with exactly ...
Scientists step closer to understanding secrets of anti-matter
2010-11-18
Researchers have trapped and held the atoms, the anti-matter counterpart of hydrogen, using an experiment called ALPHA at CERN in Switzerland. Anti-matter particles are instantly annihilated when they come into contact with matter and, until now, it has not been possible to study anti-hydrogen in any detail. The experiment has brought scientists closer to understanding the structure and composition of anti-matter.
The ALPHA experiment was developed to cool and slow down the anti-particles that make up anti-hydrogen and mix them to produce antihydrogen. Some of the ...
Study finds evidence of gender bias toward diagnosing boys with autism
2010-11-18
Social factors can play a key role in whether or not a child is diagnosed as autistic, a new study has found.
Boys were more likely to receive a diagnosis of autistic spectrum disorder (ASD) than girls, even when symptoms were equally severe, according to researchers at the universities of Exeter and Bristol.
"We wanted to find out what distinguishes those children without diagnosis but with autistic traits from those who have received a formal ASD diagnosis in the clinic," explained lead researcher Ginny Russell, from Egenis at the University of Exeter. "We thought ...
New revelations in ammonia synthesis
2010-11-18
Scientists at the University of Cambridge are working on ways to improve the efficiency of the ammonia synthesis process. With between 3-5% of the world's natural gas used to create artificial fertilizers, the new research could have major implications for both the agricultural and energy sectors.
Ammonia (NH3) is one of the most important chemicals in the modern world, due mainly to its use in the manufacture of artificial fertilisers. Ammonia synthesis (via the "Haber" or "Haber-Bosch" process) is vital to the production of 100 million tons of fertiliser per year, ...
Chemicals' study pinpoints threat to workers' lungs
2010-11-18
Tiny particles used in a range of everyday products from computers to shampoo can adversely affect the lungs in very different ways, a study has shown.
Research by the University of Edinburgh suggests that industrial manufacturers using nanoparticles should be aware of the risks that different types of nanoparticles pose to workers who handle them.
Nanoparticles – which can be 10,000 times smaller than the width of a human hair – are potentially hazardous to workers handling the chemicals used to make products as they may be at risk of inhaling them.
The particles ...